Cancer Pain Management Using a Web-based Intervention
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Oct 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new web-based program called CAI, designed to help Asian American women who have survived breast cancer manage their pain and depressive symptoms. The program builds on an existing tool, CAPA, but adds features to better meet the individual needs of participants. The goal is to see if this new approach improves how participants experience cancer pain and any accompanying depression compared to those using the original program.
To participate, women must be at least 18 years old, identify as Chinese, Korean, or Japanese, and have a history of breast cancer. They should also have experienced cancer pain and mild to moderate depressive symptoms recently, and they need access to the internet. Participants will be asked to use the new program and share their experiences over a few months. This study aims to provide valuable insights that could help improve pain management for breast cancer survivors in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women aged 18 years and older who identify as Chinese, Korean, or Japanese;
- • have had a breast cancer diagnosis in the past;
- • can read and write English, Mandarin (simplified or traditional), Korean, or Japanese;
- • have access to the internet through computers or mobile devices (mobile phones and tablets);
- • have experienced cancer pain during the past week (at least 1 on a scale from 0 to 5 \[no symptom=0, mild symptom that does not bother=1, somewhat bothering symptom=2, moderate symptom=3, severe symptom=4, and worst possible symptom=5\]);
- • have experienced depressive symptoms during the past two weeks (1 to 10 on the Patient Health Questionnaire) which is equivalent to the cut-point of minimal to moderate depression.
- Exclusion Criteria:
- • less than 18 years old because their cancer experience would be different from that of adults.
- • Those who are in treatment or not in treatment, but who were diagnosed with breast cancer within the past five years, will be excluded.
- • Those who participated in the PI's pilot studies will be excluded.
- • The participants of R33 phase will exclude those in active depression treatment regardless of their level of depression.
- • Those without Internet access will be excluded, but those with Internet access through community/group computers will be included.
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Eun Ok Im
Principal Investigator
The University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported